Concurrent Targeting of Vasopressin Receptor 2 and Somatostatin Receptors in Autosomal Dominant Polycystic Kidney Disease: A Promising Approach for Autosomal Dominant Polycystic Kidney Disease Treatment?
Marie C HoganTatyana V MasyukPublished in: Clinical journal of the American Society of Nephrology : CJASN (2023)